Forever Healthy's "Rejuvenation Now" initiative seeks to continuously identify potential rejuvenation therapies and systematically evaluates them on their risks, benefits, procedures and potential application. We do this to create transparency regarding the current state of said therapies.
Currently available risk-benefit analyses
- NEW: Skin Rejuvenation by Low-Level Light Therapy
Use of low-level light therapy aka photobiomodulation to rejuvenate the skin by stimulating collagen and elastin production, reducing age spots and wrinkles - Fisetin Senolytic Therapy
Intermittent use of high dose fisetin as a senolytic agent to remove senescent cells - NAD+ Restoration Therapy
Evaluating the use of various oral NAD precursors, transdermal patches or IVs to raise NAD+ to youthful levels
Get Notified when a new analysis is released
Upcoming work
- EDTA Therapy
Use of EDTA to prevent and reverse vascular deterioration including the capillary system - Comprehensive Lab Panel
A comprehensive lab panel for prevention, biochemical optimization, and early detection - Lipid Replacement Therapy
Use of essential phospholipids to rejuvenate cell membranes and improve their condition by replacing oxidized or broken lipids with functional ones - Dasatinib Senolytic Therapy
Intermittent use of Dasatinib and Quercetin as a combined senolytic agent to remove senescent cells - Peptide-Based Hair Regrowth Therapy
Use of PDT-DBM polypeptide to stimulate scalp hair regrowth